IRCT20081019001369N2RecruitingPhase 2
Clinical trial of berberine against COVID-19
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Patients with covid-19 symptoms
- •Indication of home quarantine and outpatient medication
Exclusion Criteria
- •Patients over 65 years of age
- •Patients connected to a catheter or under chemotherapy
- •Patients taking cytotoxic drugs or corticosteroids
- •Child patients
- •Pregnant and lactating patients
- •Diabetic patients
- •Patients with severe renal insufficiency as well as liver failure
Investigators
Similar Trials
Recruiting
Phase 2
Effect of minocycline on COVID-19Covid-19.COVID-19 DiseaseU07.1IRCT20081019001369N4Mashhad University of Medical Sciences40
Active, not recruiting
Phase 1
Treatments of COVID-19 in primary care in the NetherlandsPatients with symptomatic COVID-19 in the community and in primary care, who are at higher risk of a complicated illness course.MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862CTIS2022-501559-99-00Maastricht University682
Recruiting
Not Applicable
Randomized Clinical Trial of the antibacterial effect, clinical and radiographic success of endodontic treatment in primary teethRBR-65336kValdineia Maria Tognetti
Unknown
Phase 1
A randomized clinical trial on the antimicrobial activity and safety of 0.5% chitosan mouth sprayHealthy with ASA (American association of Anesthesiologists) class 1 and class 20.5% Chitosan, Mouth spray, Antimicrobial activity, SafetyTCTR20221129002Faculty of Dentistry, Khon Kaen University60
Unknown
Phase 2
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.Pharmacological ActionNCT04320277Hospital of Prato200